Home >> Healthcare Administration >> Pharmaceuticals >> Food & Beverage >>

Global Cancer Biomarkers Market 2015-2019

Published: Jan-2015 | Format: PDF | Technavio | Number of pages: 89 | Code: MRS - 3610

 

Biomarkers are molecules present in the blood, other body fluids such as serum, urine, or in tissue that are indicators of a disease or abnormal conditions. Biomarkers are mostly used as diagnostic tools. Biomarkers help in identifying potential drug failures in initial stages, leading to savings in time and costs. Biomarkers are becoming an essential part of the drug discovery process. Cancer Biomarkers are proteins or metabolites indicative of tumor state and progression characteristics. They are non-invasive, enable high speed cancer diagnosis and also enhance early cancer detection and screening. The best example of a cancer biomarker is that of prostate specific antigen. PSA is measured in the blood to screen for and monitor treatment for prostate cancer. PSA, as a biomarker helps the doctors to monitor the progress of the cancer. It also helps to evaluate the response of the cancer to the treatment therapy.

 

TechNavio''s analysts forecast the Global Cancer Biomarkers market to grow at a CAGR of 18.26 percent over the period 2014-2019.

 

Covered in this Report
 

TechNavio''s report, Global Cancer Biomarkers Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Cancer Biomarkers market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

 

Key Regions
 

Americas
APAC
EMEA

 

Key Vendors
 

Abbott Laboratories
Affymetrix
Illumina
Qiagen
Quest Diagnostics
Roche Diagnostics

 

Other Prominent Vendors
 

Agendia
Agilent Technologies
Alere
Ambry Genetics
Amgen
Astellas Pharma US
Astex Pharmaceuticals
Atossa Genetics
Beckman Coulter
Becton, Dickinson and Company
Biocurex
bioMA©rieux
Celldex Therapeutics
Clarient
diaDexus
DiagnoCure
Epigenomics
EUSA Pharma
Exact Sciences
Foundation Medicine
Fujirebio Diagnostics
Genomic Health
Geron
Immunomedics
Morphotek
Myriad Genetics
Nodality
Northwest Biotherapeutics
Ocimum Biosolutions
Oncothyreon
OriGene
Polymedco
Radient Pharmaceuticals
Randox Laboratories
Siemens Healthcare
US Biomarkers
Vermillion

 

Market Driver
 

Increased Prevalence of Cancer
For a full, detailed list, view our report

 

Market Challenge
 

Regulatory and Reimbursement Issues
For a full, detailed list, view our report

 

Market Trend
 

Growing Popularity of Companion Diagnostics
For a full, detailed list, view our report

 

Key Questions Answered in this Report
 

What will the market size be in 2019 and what will the growth rate be
What are the key market trends
What is driving this market
What are the challenges to market growth
Who are the key vendors in this market space
What are the market opportunities and threats faced by the key vendors
What are the strengths and weaknesses of the key vendors

Table of Contents

 

1. Executive Summary
 

2. List of Abbreviations
 

3. Scope of the Report
3.1 Market Overview
3.2 Product Offerings

 

4. Market Research Methodology
4.1 Market Research Process
4.2 Research Methodology

 

5. Introduction
 

6. Market Landscape
6.1 Market Overview
6.2 Market Size and Forecast
6.3 Five Forces Analysis

 

7. Incidence and Prevalence
 

8. Biomarkers Used in Cancer Diagnosis
8.1.1 Cancer Biomarkers : FDA Approved till 212
8.1.2 Cancer Biomarkers : FDA Approved 213

 

9. FDA Approval Process for Protein-Based Cancer Biomarkers
 

10. Geographical Segmentation
10.1 Cancer Biomarkers Market in the Americas
10.1.1 Market Size and Forecast
10.1.2 Cancer Biomarkers Market in US
10.2 Cancer Biomarkers Market in the EMEA Region
10.2.1 Market Size and Forecast
10.3 Cancer Biomarkers Market in APAC Region
10.3.1 Market Size and Forecast

 

11. Buying Criteria
 

12. Market Growth Drivers
 

13. Drivers and their Impact
 

14. Market Challenges
 

15. Impact of Drivers and Challenges
 

16. Market Trends
 

17. Trends and their Impact
 

18. Vendor Landscape
18.1 Competitive Scenario
18.1.1 Key News
18.1.2 Mergers and Acquisitions
18.2 Vendor Analysis 2014
18.3 Other Prominent Vendors

 

19. Key Vendor Analysis
19.1 Abbott Laboratories
19.1.1 Key Facts
19.1.2 Business Description
19.1.3 Business Segmentation
19.1.4 Business Strategy
19.1.5 Revenue by Business Segmentation
19.1.6 Revenue Comparison 2011 and 2012
19.1.7 Revenue by Geographical Segmentation
19.1.8 Key Information
19.1.9 SWOT Analysis
19.2 Affymetrix
19.2.1 Key Facts
19.2.2 Business Overview
19.2.3 Business Segmentation
19.2.4 Business Segmentation by Revenue 2013
19.2.5 Business Segmentation by Revenue 2012 and 2013
19.2.6 Sales by Geography
19.2.7 Business Strategy
19.2.8 Key Information
19.2.9 SWOT Analysis
19.3 Illumina
19.3.1 Key Facts
19.3.2 Business Overview
19.3.3 Business Segmentation
19.3.4 Geographical Segmentation by Revenue 2013
19.3.5 Business Strategy
19.3.6 Key Information
19.3.7 SWOT Analysis
19.4 Qiagen
19.4.1 Key Facts
19.4.2 Business Overview
19.4.3 Product Segmentation by Revenue 2013
19.4.4 Product Segmentation by Revenue 2012 and 2013
19.4.5 Geographical Segmentation by Revenue 2013
19.4.6 Business Strategy
19.4.7 Recent Developments
19.4.8 SWOT Analysis
19.5 Quest Diagnostics
19.5.1 Key Facts
19.5.2 Business Overview
19.5.3 Business Segmentation by Revenue 2013
19.5.4 Business Segmentation by Revenue 2011-2013
19.5.5 Geographical Segmentation by Revenue 2013
19.5.6 Business Strategy
19.5.7 Recent Developments
19.5.8 SWOT Analysis
19.6 Roche Diagnostics
19.6.1 Key Facts
19.6.2 Business Overview
19.6.3 Business Segmentation by Revenue 2013
19.6.4 Geographical Segmentation by Revenue 2013
19.6.5 Business Strategy
19.6.6 Key Developments
19.6.7 SWOT Analysis

 

20. Other Reports in this Series


List of Exhibits
 

Exhibit 1: Market Research Methodology
Exhibit 2: Global Cancer Biomarkers Market 2014–2019 (US$ billion)
Exhibit 3: Incidence of Various Types of Cancer in 2012
Exhibit 4: FDA Classification of Medical Devices by Type of Class
Exhibit 5: Global Cancer Biomarkers Market by Geographical Segmentation 2014
Exhibit 6: Global Cancer Biomarkers Market by Geographical Segmentation 2019
Exhibit 7: Cancer Biomarkers Market in the Americas 2014-2019 (US$ billion)
Exhibit 8: Cancer Biomarkers Market in US 2014-2019 (US$ billion)
Exhibit 9: Cancer Biomarkers Market in the EMEA Region 2014-2019 (US$ billion)
Exhibit 10: Cancer Biomarkers Market in the APAC Region 2014-2019 (US$ billion)
Exhibit 11: Global Cancer Biomarkers Market by Geographical Segmentation 2014-2019
Exhibit 12: Abbott Laboratories Inc.: Business Segmentation
Exhibit 13: Abbott Laboratories Inc.: Revenue by Business Segmentation 2012
Exhibit 14: Abbott Laboratories Inc.: Revenue by Business Segmentation 2011 and 2012 (US$ million)
Exhibit 15: Abbott Laboratories Inc.: Revenue by Geographical Segmentation 2012
Exhibit 16: Affymetrix Inc.: Business Segmentation 2013
Exhibit 17: Affymetrix Inc.: Business Segmentation by Revenue 2013
Exhibit 18: Affymetrix Inc.: Business Segmentation by Revenue 2012 and 2013 (US$ million)
Exhibit 19: Affymetrix Inc.: Sales by Geography 2013
Exhibit 20: Illumina: Business Segmentation
Exhibit 21: Illumina: Geographical Segmentation by Revenue 2013
Exhibit 22: Qiagen: Product Segmentation by Revenue 2013
Exhibit 23: Qiagen: Product Segmentation by Revenue 2012 and 2013 (US$ million)
Exhibit 24: Qiagen: Geographical Segmentation by Revenue 2013
Exhibit 25: Global Cancer Biomarkers Market: Business Segmentation by Revenue 2013
Exhibit 26: Global Cancer Biomarkers Market: Business Segmentation by Revenue 2011-2013 (US$ billion)
Exhibit 27: Global Cancer Biomarkers Market: Geographical Segmentation by Revenue 2013
Exhibit 28: Roche Diagnostics: Business Segmentation by Revenue 2013
Exhibit 29: Roche Diagnostics: Geographical Segmentation by Revenue 2013

Inquiry For Buying

Please fill your details below, to inquire about this report:
Indicates required fields

Request Sample

Please fill your details below, to receive sample report:
Indicates required fields

  • Payment Mode

COVID-19 Pandemic Impacts

Our Analysts and Consultants are working ceaselessly to congregate, identify, analyze, and portray the Actual Impacts of COVID-19 Global Pandemic in each of our published as well as ongoing research reports to Redefine and Revise Current and Future Market Trends, Growth Rates, And Market Size Projections across the Globe as well as in different Regions and individual Countries.

Single User | $(USD)2500 View Pricing